nodes	percent_of_prediction	percent_of_DWPC	metapath
Penciclovir—Entecavir—Cladribine—hematologic cancer	0.699	1	CrCrCtD
Penciclovir—Ganciclovir—SLC22A1—hematologic cancer	0.00194	0.562	CrCbGaD
Penciclovir—Aciclovir—SLC22A1—hematologic cancer	0.00151	0.437	CrCbGaD
Penciclovir—Neutropenia—Doxorubicin—hematologic cancer	0.000113	0.000379	CcSEcCtD
Penciclovir—Rash—Thalidomide—hematologic cancer	0.000112	0.000377	CcSEcCtD
Penciclovir—Dermatitis—Thalidomide—hematologic cancer	0.000112	0.000377	CcSEcCtD
Penciclovir—Dizziness—Alitretinoin—hematologic cancer	0.000112	0.000376	CcSEcCtD
Penciclovir—Diarrhoea—Vincristine—hematologic cancer	0.000112	0.000375	CcSEcCtD
Penciclovir—Headache—Thalidomide—hematologic cancer	0.000112	0.000375	CcSEcCtD
Penciclovir—Pain—Prednisolone—hematologic cancer	0.000112	0.000375	CcSEcCtD
Penciclovir—Asthenia—Gemcitabine—hematologic cancer	0.000111	0.000373	CcSEcCtD
Penciclovir—Dizziness—Ifosfamide—hematologic cancer	0.000111	0.000372	CcSEcCtD
Penciclovir—Hepatobiliary disease—Epirubicin—hematologic cancer	0.00011	0.000369	CcSEcCtD
Penciclovir—Pruritus—Gemcitabine—hematologic cancer	0.00011	0.000368	CcSEcCtD
Penciclovir—Nausea—Thiotepa—hematologic cancer	0.000109	0.000367	CcSEcCtD
Penciclovir—Feeling abnormal—Etoposide—hematologic cancer	0.000109	0.000366	CcSEcCtD
Penciclovir—Diarrhoea—Irinotecan—hematologic cancer	0.000109	0.000366	CcSEcCtD
Penciclovir—Diarrhoea—Mitoxantrone—hematologic cancer	0.000109	0.000366	CcSEcCtD
Penciclovir—Vomiting—Carmustine—hematologic cancer	0.000109	0.000365	CcSEcCtD
Penciclovir—Gastrointestinal pain—Etoposide—hematologic cancer	0.000108	0.000363	CcSEcCtD
Penciclovir—Dizziness—Vincristine—hematologic cancer	0.000108	0.000363	CcSEcCtD
Penciclovir—Rash—Carmustine—hematologic cancer	0.000108	0.000362	CcSEcCtD
Penciclovir—Dermatitis—Carmustine—hematologic cancer	0.000108	0.000362	CcSEcCtD
Penciclovir—Vomiting—Alitretinoin—hematologic cancer	0.000108	0.000362	CcSEcCtD
Penciclovir—Paraesthesia—Triamcinolone—hematologic cancer	0.000108	0.000362	CcSEcCtD
Penciclovir—Feeling abnormal—Prednisolone—hematologic cancer	0.000108	0.000361	CcSEcCtD
Penciclovir—Anaemia—Prednisone—hematologic cancer	0.000107	0.000361	CcSEcCtD
Penciclovir—Headache—Carmustine—hematologic cancer	0.000107	0.00036	CcSEcCtD
Penciclovir—Rash—Alitretinoin—hematologic cancer	0.000107	0.000359	CcSEcCtD
Penciclovir—Nervous system disorder—Dexamethasone—hematologic cancer	0.000107	0.000359	CcSEcCtD
Penciclovir—Nervous system disorder—Betamethasone—hematologic cancer	0.000107	0.000359	CcSEcCtD
Penciclovir—Dermatitis—Alitretinoin—hematologic cancer	0.000107	0.000359	CcSEcCtD
Penciclovir—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	0.000107	0.000358	CcSEcCtD
Penciclovir—Thrombocytopenia—Dexamethasone—hematologic cancer	0.000107	0.000358	CcSEcCtD
Penciclovir—Thrombocytopenia—Betamethasone—hematologic cancer	0.000107	0.000358	CcSEcCtD
Penciclovir—Vomiting—Ifosfamide—hematologic cancer	0.000107	0.000358	CcSEcCtD
Penciclovir—Hypersensitivity—Cisplatin—hematologic cancer	0.000106	0.000357	CcSEcCtD
Penciclovir—Headache—Alitretinoin—hematologic cancer	0.000106	0.000357	CcSEcCtD
Penciclovir—Angioedema—Prednisone—hematologic cancer	0.000106	0.000357	CcSEcCtD
Penciclovir—Diarrhoea—Gemcitabine—hematologic cancer	0.000106	0.000356	CcSEcCtD
Penciclovir—Nausea—Thalidomide—hematologic cancer	0.000106	0.000355	CcSEcCtD
Penciclovir—Rash—Ifosfamide—hematologic cancer	0.000106	0.000355	CcSEcCtD
Penciclovir—Dermatitis—Ifosfamide—hematologic cancer	0.000106	0.000354	CcSEcCtD
Penciclovir—Erythema multiforme—Methotrexate—hematologic cancer	0.000105	0.000354	CcSEcCtD
Penciclovir—Dizziness—Irinotecan—hematologic cancer	0.000105	0.000353	CcSEcCtD
Penciclovir—Urticaria—Etoposide—hematologic cancer	0.000105	0.000353	CcSEcCtD
Penciclovir—Abdominal pain—Etoposide—hematologic cancer	0.000105	0.000351	CcSEcCtD
Penciclovir—Hypoaesthesia—Epirubicin—hematologic cancer	0.000104	0.000349	CcSEcCtD
Penciclovir—Vomiting—Vincristine—hematologic cancer	0.000104	0.000349	CcSEcCtD
Penciclovir—Urticaria—Prednisolone—hematologic cancer	0.000104	0.000348	CcSEcCtD
Penciclovir—Asthenia—Cisplatin—hematologic cancer	0.000104	0.000348	CcSEcCtD
Penciclovir—Cardiac disorder—Methotrexate—hematologic cancer	0.000104	0.000348	CcSEcCtD
Penciclovir—Fatigue—Triamcinolone—hematologic cancer	0.000103	0.000348	CcSEcCtD
Penciclovir—Rash—Vincristine—hematologic cancer	0.000103	0.000346	CcSEcCtD
Penciclovir—Dermatitis—Vincristine—hematologic cancer	0.000103	0.000346	CcSEcCtD
Penciclovir—Pain—Triamcinolone—hematologic cancer	0.000103	0.000345	CcSEcCtD
Penciclovir—Headache—Vincristine—hematologic cancer	0.000102	0.000344	CcSEcCtD
Penciclovir—Hepatobiliary disease—Doxorubicin—hematologic cancer	0.000102	0.000342	CcSEcCtD
Penciclovir—Nausea—Carmustine—hematologic cancer	0.000102	0.000341	CcSEcCtD
Penciclovir—Vomiting—Mitoxantrone—hematologic cancer	0.000101	0.00034	CcSEcCtD
Penciclovir—Vomiting—Irinotecan—hematologic cancer	0.000101	0.00034	CcSEcCtD
Penciclovir—Nausea—Alitretinoin—hematologic cancer	0.000101	0.000338	CcSEcCtD
Penciclovir—Rash—Mitoxantrone—hematologic cancer	0.0001	0.000337	CcSEcCtD
Penciclovir—Rash—Irinotecan—hematologic cancer	0.0001	0.000337	CcSEcCtD
Penciclovir—Dermatitis—Irinotecan—hematologic cancer	0.0001	0.000337	CcSEcCtD
Penciclovir—Dermatitis—Mitoxantrone—hematologic cancer	0.0001	0.000337	CcSEcCtD
Penciclovir—Headache—Irinotecan—hematologic cancer	9.96e-05	0.000335	CcSEcCtD
Penciclovir—Headache—Mitoxantrone—hematologic cancer	9.96e-05	0.000335	CcSEcCtD
Penciclovir—Nausea—Ifosfamide—hematologic cancer	9.95e-05	0.000334	CcSEcCtD
Penciclovir—Feeling abnormal—Triamcinolone—hematologic cancer	9.89e-05	0.000332	CcSEcCtD
Penciclovir—Diarrhoea—Cisplatin—hematologic cancer	9.88e-05	0.000332	CcSEcCtD
Penciclovir—Erythema multiforme—Epirubicin—hematologic cancer	9.87e-05	0.000332	CcSEcCtD
Penciclovir—Vomiting—Gemcitabine—hematologic cancer	9.85e-05	0.000331	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	9.82e-05	0.00033	CcSEcCtD
Penciclovir—Paraesthesia—Dexamethasone—hematologic cancer	9.78e-05	0.000328	CcSEcCtD
Penciclovir—Paraesthesia—Betamethasone—hematologic cancer	9.78e-05	0.000328	CcSEcCtD
Penciclovir—Mental disorder—Methotrexate—hematologic cancer	9.77e-05	0.000328	CcSEcCtD
Penciclovir—Rash—Gemcitabine—hematologic cancer	9.77e-05	0.000328	CcSEcCtD
Penciclovir—Dermatitis—Gemcitabine—hematologic cancer	9.76e-05	0.000328	CcSEcCtD
Penciclovir—Hypersensitivity—Etoposide—hematologic cancer	9.75e-05	0.000327	CcSEcCtD
Penciclovir—Erythema—Methotrexate—hematologic cancer	9.71e-05	0.000326	CcSEcCtD
Penciclovir—Headache—Gemcitabine—hematologic cancer	9.71e-05	0.000326	CcSEcCtD
Penciclovir—Nausea—Vincristine—hematologic cancer	9.7e-05	0.000326	CcSEcCtD
Penciclovir—Cardiac disorder—Epirubicin—hematologic cancer	9.69e-05	0.000325	CcSEcCtD
Penciclovir—Hypersensitivity—Prednisolone—hematologic cancer	9.61e-05	0.000323	CcSEcCtD
Penciclovir—Hypoaesthesia—Doxorubicin—hematologic cancer	9.61e-05	0.000323	CcSEcCtD
Penciclovir—Urticaria—Triamcinolone—hematologic cancer	9.53e-05	0.00032	CcSEcCtD
Penciclovir—Dysgeusia—Methotrexate—hematologic cancer	9.51e-05	0.000319	CcSEcCtD
Penciclovir—Asthenia—Etoposide—hematologic cancer	9.49e-05	0.000319	CcSEcCtD
Penciclovir—Nausea—Irinotecan—hematologic cancer	9.45e-05	0.000317	CcSEcCtD
Penciclovir—Nausea—Mitoxantrone—hematologic cancer	9.45e-05	0.000317	CcSEcCtD
Penciclovir—Fatigue—Dexamethasone—hematologic cancer	9.39e-05	0.000315	CcSEcCtD
Penciclovir—Fatigue—Betamethasone—hematologic cancer	9.39e-05	0.000315	CcSEcCtD
Penciclovir—Pruritus—Etoposide—hematologic cancer	9.36e-05	0.000314	CcSEcCtD
Penciclovir—Pain—Betamethasone—hematologic cancer	9.31e-05	0.000313	CcSEcCtD
Penciclovir—Pain—Dexamethasone—hematologic cancer	9.31e-05	0.000313	CcSEcCtD
Penciclovir—Nervous system disorder—Prednisone—hematologic cancer	9.3e-05	0.000312	CcSEcCtD
Penciclovir—Skin disorder—Prednisone—hematologic cancer	9.21e-05	0.000309	CcSEcCtD
Penciclovir—Nausea—Gemcitabine—hematologic cancer	9.2e-05	0.000309	CcSEcCtD
Penciclovir—Vomiting—Cisplatin—hematologic cancer	9.18e-05	0.000308	CcSEcCtD
Penciclovir—Mental disorder—Epirubicin—hematologic cancer	9.15e-05	0.000307	CcSEcCtD
Penciclovir—Erythema multiforme—Doxorubicin—hematologic cancer	9.13e-05	0.000307	CcSEcCtD
Penciclovir—Rash—Cisplatin—hematologic cancer	9.11e-05	0.000306	CcSEcCtD
Penciclovir—Dermatitis—Cisplatin—hematologic cancer	9.1e-05	0.000306	CcSEcCtD
Penciclovir—Erythema—Epirubicin—hematologic cancer	9.09e-05	0.000305	CcSEcCtD
Penciclovir—Diarrhoea—Etoposide—hematologic cancer	9.05e-05	0.000304	CcSEcCtD
Penciclovir—Anaemia—Methotrexate—hematologic cancer	8.98e-05	0.000301	CcSEcCtD
Penciclovir—Feeling abnormal—Dexamethasone—hematologic cancer	8.97e-05	0.000301	CcSEcCtD
Penciclovir—Feeling abnormal—Betamethasone—hematologic cancer	8.97e-05	0.000301	CcSEcCtD
Penciclovir—Cardiac disorder—Doxorubicin—hematologic cancer	8.96e-05	0.000301	CcSEcCtD
Penciclovir—Flatulence—Epirubicin—hematologic cancer	8.95e-05	0.000301	CcSEcCtD
Penciclovir—Gastrointestinal pain—Betamethasone—hematologic cancer	8.9e-05	0.000299	CcSEcCtD
Penciclovir—Gastrointestinal pain—Dexamethasone—hematologic cancer	8.9e-05	0.000299	CcSEcCtD
Penciclovir—Dysgeusia—Epirubicin—hematologic cancer	8.9e-05	0.000299	CcSEcCtD
Penciclovir—Hypersensitivity—Triamcinolone—hematologic cancer	8.84e-05	0.000297	CcSEcCtD
Penciclovir—Dizziness—Etoposide—hematologic cancer	8.75e-05	0.000294	CcSEcCtD
Penciclovir—Leukopenia—Methotrexate—hematologic cancer	8.69e-05	0.000292	CcSEcCtD
Penciclovir—Urticaria—Dexamethasone—hematologic cancer	8.65e-05	0.000291	CcSEcCtD
Penciclovir—Urticaria—Betamethasone—hematologic cancer	8.65e-05	0.000291	CcSEcCtD
Penciclovir—Dizziness—Prednisolone—hematologic cancer	8.63e-05	0.00029	CcSEcCtD
Penciclovir—Asthenia—Triamcinolone—hematologic cancer	8.61e-05	0.000289	CcSEcCtD
Penciclovir—Abdominal pain—Dexamethasone—hematologic cancer	8.61e-05	0.000289	CcSEcCtD
Penciclovir—Abdominal pain—Betamethasone—hematologic cancer	8.61e-05	0.000289	CcSEcCtD
Penciclovir—Nausea—Cisplatin—hematologic cancer	8.58e-05	0.000288	CcSEcCtD
Penciclovir—Paraesthesia—Prednisone—hematologic cancer	8.52e-05	0.000286	CcSEcCtD
Penciclovir—Pruritus—Triamcinolone—hematologic cancer	8.49e-05	0.000285	CcSEcCtD
Penciclovir—Mental disorder—Doxorubicin—hematologic cancer	8.46e-05	0.000284	CcSEcCtD
Penciclovir—Vomiting—Etoposide—hematologic cancer	8.41e-05	0.000283	CcSEcCtD
Penciclovir—Erythema—Doxorubicin—hematologic cancer	8.41e-05	0.000282	CcSEcCtD
Penciclovir—Anaemia—Epirubicin—hematologic cancer	8.4e-05	0.000282	CcSEcCtD
Penciclovir—Rash—Etoposide—hematologic cancer	8.34e-05	0.00028	CcSEcCtD
Penciclovir—Dermatitis—Etoposide—hematologic cancer	8.33e-05	0.00028	CcSEcCtD
Penciclovir—Headache—Etoposide—hematologic cancer	8.29e-05	0.000278	CcSEcCtD
Penciclovir—Flatulence—Doxorubicin—hematologic cancer	8.29e-05	0.000278	CcSEcCtD
Penciclovir—Dysgeusia—Doxorubicin—hematologic cancer	8.23e-05	0.000277	CcSEcCtD
Penciclovir—Rash—Prednisolone—hematologic cancer	8.23e-05	0.000276	CcSEcCtD
Penciclovir—Dermatitis—Prednisolone—hematologic cancer	8.22e-05	0.000276	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	8.21e-05	0.000276	CcSEcCtD
Penciclovir—Fatigue—Prednisone—hematologic cancer	8.18e-05	0.000275	CcSEcCtD
Penciclovir—Headache—Prednisolone—hematologic cancer	8.18e-05	0.000275	CcSEcCtD
Penciclovir—Leukopenia—Epirubicin—hematologic cancer	8.13e-05	0.000273	CcSEcCtD
Penciclovir—Palpitations—Epirubicin—hematologic cancer	8.03e-05	0.00027	CcSEcCtD
Penciclovir—Confusional state—Methotrexate—hematologic cancer	7.99e-05	0.000268	CcSEcCtD
Penciclovir—Dizziness—Triamcinolone—hematologic cancer	7.94e-05	0.000267	CcSEcCtD
Penciclovir—Nausea—Etoposide—hematologic cancer	7.86e-05	0.000264	CcSEcCtD
Penciclovir—Feeling abnormal—Prednisone—hematologic cancer	7.81e-05	0.000262	CcSEcCtD
Penciclovir—Asthenia—Betamethasone—hematologic cancer	7.81e-05	0.000262	CcSEcCtD
Penciclovir—Asthenia—Dexamethasone—hematologic cancer	7.81e-05	0.000262	CcSEcCtD
Penciclovir—Nervous system disorder—Methotrexate—hematologic cancer	7.77e-05	0.000261	CcSEcCtD
Penciclovir—Anaemia—Doxorubicin—hematologic cancer	7.77e-05	0.000261	CcSEcCtD
Penciclovir—Thrombocytopenia—Methotrexate—hematologic cancer	7.76e-05	0.000261	CcSEcCtD
Penciclovir—Gastrointestinal pain—Prednisone—hematologic cancer	7.75e-05	0.00026	CcSEcCtD
Penciclovir—Nausea—Prednisolone—hematologic cancer	7.75e-05	0.00026	CcSEcCtD
Penciclovir—Pruritus—Betamethasone—hematologic cancer	7.7e-05	0.000259	CcSEcCtD
Penciclovir—Pruritus—Dexamethasone—hematologic cancer	7.7e-05	0.000259	CcSEcCtD
Penciclovir—Skin disorder—Methotrexate—hematologic cancer	7.7e-05	0.000259	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	7.68e-05	0.000258	CcSEcCtD
Penciclovir—Vomiting—Triamcinolone—hematologic cancer	7.63e-05	0.000256	CcSEcCtD
Penciclovir—Rash—Triamcinolone—hematologic cancer	7.57e-05	0.000254	CcSEcCtD
Penciclovir—Dermatitis—Triamcinolone—hematologic cancer	7.56e-05	0.000254	CcSEcCtD
Penciclovir—Urticaria—Prednisone—hematologic cancer	7.53e-05	0.000253	CcSEcCtD
Penciclovir—Leukopenia—Doxorubicin—hematologic cancer	7.53e-05	0.000253	CcSEcCtD
Penciclovir—Headache—Triamcinolone—hematologic cancer	7.52e-05	0.000253	CcSEcCtD
Penciclovir—Abdominal pain—Prednisone—hematologic cancer	7.5e-05	0.000252	CcSEcCtD
Penciclovir—Confusional state—Epirubicin—hematologic cancer	7.48e-05	0.000251	CcSEcCtD
Penciclovir—Diarrhoea—Betamethasone—hematologic cancer	7.45e-05	0.00025	CcSEcCtD
Penciclovir—Diarrhoea—Dexamethasone—hematologic cancer	7.45e-05	0.00025	CcSEcCtD
Penciclovir—Palpitations—Doxorubicin—hematologic cancer	7.43e-05	0.00025	CcSEcCtD
Penciclovir—Nervous system disorder—Epirubicin—hematologic cancer	7.27e-05	0.000244	CcSEcCtD
Penciclovir—Thrombocytopenia—Epirubicin—hematologic cancer	7.26e-05	0.000244	CcSEcCtD
Penciclovir—Skin disorder—Epirubicin—hematologic cancer	7.2e-05	0.000242	CcSEcCtD
Penciclovir—Dizziness—Betamethasone—hematologic cancer	7.2e-05	0.000242	CcSEcCtD
Penciclovir—Dizziness—Dexamethasone—hematologic cancer	7.2e-05	0.000242	CcSEcCtD
Penciclovir—Nausea—Triamcinolone—hematologic cancer	7.13e-05	0.000239	CcSEcCtD
Penciclovir—Paraesthesia—Methotrexate—hematologic cancer	7.12e-05	0.000239	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	7.11e-05	0.000239	CcSEcCtD
Penciclovir—Somnolence—Methotrexate—hematologic cancer	7.05e-05	0.000237	CcSEcCtD
Penciclovir—Hypersensitivity—Prednisone—hematologic cancer	6.99e-05	0.000235	CcSEcCtD
Penciclovir—Vomiting—Betamethasone—hematologic cancer	6.92e-05	0.000233	CcSEcCtD
Penciclovir—Vomiting—Dexamethasone—hematologic cancer	6.92e-05	0.000233	CcSEcCtD
Penciclovir—Confusional state—Doxorubicin—hematologic cancer	6.92e-05	0.000232	CcSEcCtD
Penciclovir—Rash—Dexamethasone—hematologic cancer	6.87e-05	0.000231	CcSEcCtD
Penciclovir—Rash—Betamethasone—hematologic cancer	6.87e-05	0.000231	CcSEcCtD
Penciclovir—Dermatitis—Dexamethasone—hematologic cancer	6.86e-05	0.00023	CcSEcCtD
Penciclovir—Dermatitis—Betamethasone—hematologic cancer	6.86e-05	0.00023	CcSEcCtD
Penciclovir—Fatigue—Methotrexate—hematologic cancer	6.83e-05	0.000229	CcSEcCtD
Penciclovir—Headache—Betamethasone—hematologic cancer	6.82e-05	0.000229	CcSEcCtD
Penciclovir—Headache—Dexamethasone—hematologic cancer	6.82e-05	0.000229	CcSEcCtD
Penciclovir—Asthenia—Prednisone—hematologic cancer	6.8e-05	0.000229	CcSEcCtD
Penciclovir—Pain—Methotrexate—hematologic cancer	6.78e-05	0.000228	CcSEcCtD
Penciclovir—Nervous system disorder—Doxorubicin—hematologic cancer	6.73e-05	0.000226	CcSEcCtD
Penciclovir—Thrombocytopenia—Doxorubicin—hematologic cancer	6.72e-05	0.000226	CcSEcCtD
Penciclovir—Pruritus—Prednisone—hematologic cancer	6.71e-05	0.000225	CcSEcCtD
Penciclovir—Skin disorder—Doxorubicin—hematologic cancer	6.67e-05	0.000224	CcSEcCtD
Penciclovir—Paraesthesia—Epirubicin—hematologic cancer	6.66e-05	0.000224	CcSEcCtD
Penciclovir—Somnolence—Epirubicin—hematologic cancer	6.59e-05	0.000221	CcSEcCtD
Penciclovir—Feeling abnormal—Methotrexate—hematologic cancer	6.53e-05	0.000219	CcSEcCtD
Penciclovir—Diarrhoea—Prednisone—hematologic cancer	6.49e-05	0.000218	CcSEcCtD
Penciclovir—Gastrointestinal pain—Methotrexate—hematologic cancer	6.48e-05	0.000218	CcSEcCtD
Penciclovir—Nausea—Dexamethasone—hematologic cancer	6.47e-05	0.000217	CcSEcCtD
Penciclovir—Nausea—Betamethasone—hematologic cancer	6.47e-05	0.000217	CcSEcCtD
Penciclovir—Fatigue—Epirubicin—hematologic cancer	6.39e-05	0.000215	CcSEcCtD
Penciclovir—Pain—Epirubicin—hematologic cancer	6.34e-05	0.000213	CcSEcCtD
Penciclovir—Urticaria—Methotrexate—hematologic cancer	6.3e-05	0.000211	CcSEcCtD
Penciclovir—Dizziness—Prednisone—hematologic cancer	6.27e-05	0.000211	CcSEcCtD
Penciclovir—Abdominal pain—Methotrexate—hematologic cancer	6.26e-05	0.00021	CcSEcCtD
Penciclovir—Paraesthesia—Doxorubicin—hematologic cancer	6.16e-05	0.000207	CcSEcCtD
Penciclovir—Feeling abnormal—Epirubicin—hematologic cancer	6.11e-05	0.000205	CcSEcCtD
Penciclovir—Somnolence—Doxorubicin—hematologic cancer	6.1e-05	0.000205	CcSEcCtD
Penciclovir—Gastrointestinal pain—Epirubicin—hematologic cancer	6.06e-05	0.000204	CcSEcCtD
Penciclovir—Vomiting—Prednisone—hematologic cancer	6.03e-05	0.000203	CcSEcCtD
Penciclovir—Rash—Prednisone—hematologic cancer	5.98e-05	0.000201	CcSEcCtD
Penciclovir—Dermatitis—Prednisone—hematologic cancer	5.97e-05	0.000201	CcSEcCtD
Penciclovir—Headache—Prednisone—hematologic cancer	5.94e-05	0.0002	CcSEcCtD
Penciclovir—Fatigue—Doxorubicin—hematologic cancer	5.92e-05	0.000199	CcSEcCtD
Penciclovir—Urticaria—Epirubicin—hematologic cancer	5.89e-05	0.000198	CcSEcCtD
Penciclovir—Pain—Doxorubicin—hematologic cancer	5.87e-05	0.000197	CcSEcCtD
Penciclovir—Abdominal pain—Epirubicin—hematologic cancer	5.86e-05	0.000197	CcSEcCtD
Penciclovir—Hypersensitivity—Methotrexate—hematologic cancer	5.84e-05	0.000196	CcSEcCtD
Penciclovir—Asthenia—Methotrexate—hematologic cancer	5.69e-05	0.000191	CcSEcCtD
Penciclovir—Feeling abnormal—Doxorubicin—hematologic cancer	5.65e-05	0.00019	CcSEcCtD
Penciclovir—Nausea—Prednisone—hematologic cancer	5.63e-05	0.000189	CcSEcCtD
Penciclovir—Gastrointestinal pain—Doxorubicin—hematologic cancer	5.61e-05	0.000188	CcSEcCtD
Penciclovir—Pruritus—Methotrexate—hematologic cancer	5.61e-05	0.000188	CcSEcCtD
Penciclovir—Hypersensitivity—Epirubicin—hematologic cancer	5.46e-05	0.000184	CcSEcCtD
Penciclovir—Urticaria—Doxorubicin—hematologic cancer	5.45e-05	0.000183	CcSEcCtD
Penciclovir—Abdominal pain—Doxorubicin—hematologic cancer	5.42e-05	0.000182	CcSEcCtD
Penciclovir—Diarrhoea—Methotrexate—hematologic cancer	5.42e-05	0.000182	CcSEcCtD
Penciclovir—Asthenia—Epirubicin—hematologic cancer	5.32e-05	0.000179	CcSEcCtD
Penciclovir—Pruritus—Epirubicin—hematologic cancer	5.25e-05	0.000176	CcSEcCtD
Penciclovir—Dizziness—Methotrexate—hematologic cancer	5.24e-05	0.000176	CcSEcCtD
Penciclovir—Diarrhoea—Epirubicin—hematologic cancer	5.07e-05	0.00017	CcSEcCtD
Penciclovir—Hypersensitivity—Doxorubicin—hematologic cancer	5.06e-05	0.00017	CcSEcCtD
Penciclovir—Vomiting—Methotrexate—hematologic cancer	5.04e-05	0.000169	CcSEcCtD
Penciclovir—Rash—Methotrexate—hematologic cancer	5e-05	0.000168	CcSEcCtD
Penciclovir—Dermatitis—Methotrexate—hematologic cancer	4.99e-05	0.000168	CcSEcCtD
Penciclovir—Headache—Methotrexate—hematologic cancer	4.96e-05	0.000167	CcSEcCtD
Penciclovir—Asthenia—Doxorubicin—hematologic cancer	4.92e-05	0.000165	CcSEcCtD
Penciclovir—Dizziness—Epirubicin—hematologic cancer	4.9e-05	0.000165	CcSEcCtD
Penciclovir—Pruritus—Doxorubicin—hematologic cancer	4.86e-05	0.000163	CcSEcCtD
Penciclovir—Vomiting—Epirubicin—hematologic cancer	4.72e-05	0.000158	CcSEcCtD
Penciclovir—Nausea—Methotrexate—hematologic cancer	4.71e-05	0.000158	CcSEcCtD
Penciclovir—Diarrhoea—Doxorubicin—hematologic cancer	4.7e-05	0.000158	CcSEcCtD
Penciclovir—Rash—Epirubicin—hematologic cancer	4.68e-05	0.000157	CcSEcCtD
Penciclovir—Dermatitis—Epirubicin—hematologic cancer	4.67e-05	0.000157	CcSEcCtD
Penciclovir—Headache—Epirubicin—hematologic cancer	4.65e-05	0.000156	CcSEcCtD
Penciclovir—Dizziness—Doxorubicin—hematologic cancer	4.54e-05	0.000152	CcSEcCtD
Penciclovir—Nausea—Epirubicin—hematologic cancer	4.41e-05	0.000148	CcSEcCtD
Penciclovir—Vomiting—Doxorubicin—hematologic cancer	4.36e-05	0.000147	CcSEcCtD
Penciclovir—Rash—Doxorubicin—hematologic cancer	4.33e-05	0.000145	CcSEcCtD
Penciclovir—Dermatitis—Doxorubicin—hematologic cancer	4.32e-05	0.000145	CcSEcCtD
Penciclovir—Headache—Doxorubicin—hematologic cancer	4.3e-05	0.000144	CcSEcCtD
Penciclovir—Nausea—Doxorubicin—hematologic cancer	4.08e-05	0.000137	CcSEcCtD
